Edwards Lifesciences Corporation

NYSE:EW

Medical - Devices

Healthcare
$105.23 +0.57%

+$0.49 today

Market cap
$60.51B
Beta
0.87
P/E (TTM)
46.2
EPS (TTM)
$1.89
52W Low $72.30High $89.60

Volume 3.92M

Average 5.02M

EW Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Edwards Lifesciences CorporationNYSE: EW

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin holds steady near 77.6%

Gross margin was 77.6% in Q2 FY2026, down 0.1 pp from a year earlier. On a trailing-twelve-month basis it was 78.0%, down 0.9 pp year over year. Over 3 fiscal years it narrowed by 0.2 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
77.6%-0.6 pp QoQ
Last fiscal yearDec 2025
78.1%-1.3 pp YoY
LTMJun 2026
78.0%-0.9 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-0.1 pp——
1 year-1.3 pp——
3 years-0.2 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
78.1%
Year-over-year change
-1.3pp

Gross Margin vs competitors

How EW compares with its peers on the latest reported figures

  • EW's LTM Jun 2026 gross margin of 78.0% is the highest of the 6 companies compared; the peer median is 67.2%.
  • Its year-over-year change of -0.9 pp is the 4th highest of 6, against a peer median of -0.6 pp.
  • Over three fiscal years its change of -0.2 pp compares with a peer median of -1.5 pp.
EW Competitors Peer median
Gross Margin for EW and competitors
Company Period LTM level YoY 3-year change
EWEdwards Lifesciences CorporationLTM Jun 202678.0% -0.9 pp-0.2 pp
LIVNLivaNova PLCLTM Sep 202667.9% -0.6 pp-1.5 pp
PENPenumbra, Inc.LTM Jun 202667.8% +1.4 pp+4.0 pp
ISRGIntuitive Surgical, Inc.LTM Sep 202667.2% +0.8 pp-1.4 pp
AORTArtivion, Inc.LTM Mar 202662.9% -1.0 pp-3.3 pp
AVRAnteris Technologies Global Corp.LTM Mar 202628.3% -24.8 pp-25.9 pp
Peer median (excluding EW) 67.2%-0.6 pp-1.5 pp

Competitors are the stored peer set for EW. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.23B5.38B5.01B5.44B6.07B
Cost of Revenue1.23B1.17B1.04B1.12B1.33B
Gross Profit4.01B4.22B3.97B4.32B4.74B
Gross Margin76.6%78.3%79.3%79.5%78.1%
Research & Development903.1M945.2M962.9M1.05B1.08B
Selling, General & Admin1.49B1.57B1.58B1.79B2.09B
Operating Expenses2.4B2.51B2.55B2.94B3.1B
Depreciation & Amortization134.8M139.6M144.9M155.2M156.6M
EBITDA1.86B1.93B1.53B1.72B1.43B
EBITDA Margin35.6%35.9%30.6%31.7%23.6%
Operating Income1.61B1.7B1.43B1.38B1.64B
Operating Margin30.8%31.6%28.5%25.3%27.0%
Interest Income17.4M35.5M67.2M120.3M148.4M
Interest Expense24.8M26.2M17.6M19.8M0
Other Income / Expenses91.6M65M(54.9M)169.4M(363.3M)
Income Before Tax1.7B1.77B1.37B1.55B1.27B
Pre-Tax Margin32.5%32.8%27.4%28.5%21.0%
Income Tax Expense198.9M245.5M152.4M152.1M216.9M
Net Income1.5B1.52B1.4B4.17B1.07B
Net Margin28.7%28.3%28.0%76.7%17.7%
EPS (Basic)2.412.462.316.981.84
EPS (Diluted)2.382.442.306.971.83
Weighted Avg Shares623.3M619M606.7M597.7M584.8M
Weighted Avg Shares (Diluted)631.2M624.2M609.4M599.3M585.8M

Edwards Lifesciences Corporation

NYSE:EW

Intrinsic Alpha fair value

Locked

Current Price

$105.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.